State Street Health Care ... (XLV)
NYSEArca: XLV
· Echtzeitkurs · USD
169.73
+2.68 (1.60%)
Zum Schluss: Aug 18, 2026, 3:59 PM
State Street Health Care Select Sector SPDR ETF (XLV) ETF Price, Holdings & Analysis
1.60% (1D)
| Geld | 0 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 41.75 Mrd |
| NAV | 167.36 |
| Beta | 0.51 |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 30.25 |
| Ausstehende Anteile | 197.42 Mio |
| Auflagedatum | Dec 16, 1998 |
| Brief | 0 |
| Volumen | 7,517,642 |
| Ø Vol. (20D) | 10,262,164 |
| Eröffnung | 168.67 |
| Vortagesschluss | 167.05 |
| Tagesspanne | 168.45 - 170.30 |
| 52-Wk Range | 133.73 - 170.30 |
| Positionen | k.A. |
| Kostenquote | 0.08% |
Über XLV
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Anlageklasse Equity
Tickersymbol XLV
Auflagedatum Dec 16, 1998
Anbieter State Street Investment Management
Website Fonds-Homepage
Börse NYSEArca
Top 10 Positionen 60.89% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Eli Lilly And Co | LLY | 15.47% |
| Johnson & Johnson | JNJ | 10.51% |
| Abbvie Inc | ABBV | 7.55% |
| Unitedhealth Group I... | UNH | 6.41% |
| Merck & Co Inc | MRK | 5.47% |
| Thermo Fisher Scient... | TMO | 3.63% |
| Amgen Inc | AMGN | 3.54% |
| Abbott Laboratories | ABT | 3.13% |
| Gilead Sciences Inc | GILD | 2.75% |
| Pfizer Inc | PFE | 2.43% |
Dividenden Dividendenrendite 1.49%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Jun 22, 2026 | $0.6560 | k.A. |
| Mar 23, 2026 | $0.5950 | k.A. |
| Dec 22, 2025 | $0.6570 | k.A. |
| Sep 22, 2025 | $0.6250 | k.A. |
| Jun 23, 2025 | $0.6300 | k.A. |
Seite 1 von 2